Client News

Newron reports compelling topline results from all patients in Study 014, its Phase II clinical trial evaluating evenamide as add-on therapy for treatment-resistant schizophrenia

Andera Partners co-leads $25m extension round for FIRE1, an Irish medtech developing breakthrough technology for patients with heart failure

Mainz Biomed Announces Partnership with Labor Staber to Expand ColoAlert Commercialization in Germany

ONWARD to publish full year 2022 financial results and host webcast on March 28, 2023

ONWARD does not hold cash deposits at Silicon Valley Bank

Mainz Biomed launches number of educational events in Germany to raise awareness for CRC screening and early detection

Carbios joins Ellen MacArthur Foundation’s circular economy network and aims to “make plastic waste and pollution a thing of the past”

Imcyse Announces completion of enrollment in Phase 2 IMPACT trial of IMCY-0098 for Type 1 diabetes

Mainz Biomed recognizes Colorectal Cancer Awareness Month throughout “blue” March 2023

Carbios doubles its number of granted patents in two years for its proprietary enzymatic technologies